Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for high unmet need ...

2024 was primarily the result of an increase in revenue recognized under the Prevail agreement as well as new license agreements with TG Therapeutics and Caribou Biosciences in the year ended ...

Others include a partnership between Biogen and Sangamo and Eli Lilly's $1 billion takeover of Prevail in 2020 ... drug developers including Gain Therapeutics, MODAG, and Alterity Therapeutics.

For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover, develop and deliver innovative medicines that help patients prevail ... which was a cancer therapeutics company ...

Who Will Prevail? The anticipation is palpable as Alavés prepares to face Rayo Vallecano in a highly anticipated La Liga clash. This match not only signifies a contest between two distinct playing ...

Who Will Prevail in the Derby? The anticipation is palpable as La Liga fans eagerly await the upcoming clash between Real Betis and Sevilla. This derby match not only stirs the emotions of supporters ...

Qualcomm Inc. has launched a global antitrust campaign against Arm Holdings Plc as the two longtime business partners jockey ...

Trump's new series of tariffs on auto industry. Energy executives wary of trade policy. Copper prices hit another record high ...

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications ...

He added that he hoped "diplomacy will prevail in negotiations with such a strategic ally like the United States, over a fundamental market for Italy, indispensable and not replaceable". Trump's ...